ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $144,000 | -25.8% | 2,400 | +4.3% | 0.01% | -28.6% |
| Q2 2019 | $194,000 | -11.8% | 2,300 | 0.0% | 0.01% | -22.2% |
| Q1 2019 | $220,000 | +35.0% | 2,300 | 0.0% | 0.01% | +28.6% |
| Q4 2018 | $163,000 | -13.3% | 2,300 | +4.5% | 0.01% | 0.0% |
| Q3 2018 | $188,000 | +1.6% | 2,200 | +37.5% | 0.01% | 0.0% |
| Q2 2018 | $185,000 | +43.4% | 1,600 | 0.0% | 0.01% | +40.0% |
| Q1 2018 | $129,000 | +658.8% | 1,600 | +220.0% | 0.01% | +400.0% |
| Q4 2016 | $17,000 | +30.8% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $13,000 | -96.0% | 500 | -92.1% | 0.00% | -80.0% |
| Q2 2016 | $324,000 | +2600.0% | 6,292 | +1505.1% | 0.01% | – |
| Q1 2016 | $12,000 | – | 392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,599,109 | $63,277,000 | 8.68% |
| SENZAR ASSET MANAGEMENT, LLC | 566,903 | $22,432,000 | 6.58% |
| Sarissa Capital Management LP | 105,000 | $4,155,000 | 1.60% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 136,637 | $5,407,000 | 1.41% |
| RA Capital Management | 250,000 | $9,893,000 | 1.17% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 110,515 | $4,373,000 | 0.99% |
| Ghost Tree Capital, LLC | 35,000 | $1,385,000 | 0.75% |
| WALL STREET ASSOCIATES | 159,100 | $6,296,000 | 0.65% |
| BAILARD, INC. | 91,500 | $3,621,000 | 0.56% |
| EAM Investors, LLC | 62,768 | $2,484,000 | 0.50% |